All Case Studies
As of Febrary, 2026
| Project | Modality | Area | Development Stage | Status | Partner |
|---|---|---|---|---|---|
| RK001 | Antibody （Nivolumab） |
Therapeutics (Immunooncotherapy) |
Technology development |
Completed |
 |
| RK002 | Antibody （Daratumumab） |
Therapeutics (Oncology) |
Technology development |
Completed |
|
| RK003 | Protein | Therapeutics (Rare Disease) |
Undisclosed |
Completed |
 |
| RK004 | Protein | Undisclosed |
Undisclosed |
Completed |
 |
| RK006 | Protein | Undisclosed |
Undisclosed |
Completed | Undisclosed |
| RK007 | Protein | Undisclosed |
Undisclosed |
Completed |
 |
| RK008 | Protein | Undisclosed |
Undisclosed |
Completed | Undisclosed |
| RK009 | Protein | Vaccines (Infectious diseases) |
Research collaboration |
Working |
 |
| RK010 | Protein | Undisclosed |
Undisclosed |
Completed | Undisclosed |
| RK011 | Protein | Undisclosed |
Undisclosed |
Completed |
|
| RK012 | Protein | Undisclosed |
Undisclosed |
Completed | Undisclosed |
| RK013 | Protein | Undisclosed |
Undisclosed |
Working | Undisclosed |
| RK014 | Protein | Undisclosed |
Undisclosed |
Working | Undisclosed |
| RK015 | Protein | Undisclosed |
Undisclosed |
Completed |
|
| RK016 | Protein | Undisclosed |
Undisclosed |
Completed |
|
| RK017 | Protein | Undisclosed |
Undisclosed |
Working | Undisclosed |
| RK018 | Protein | Undisclosed |
Undisclosed |
Working | Undisclosed |
| RK019 | Protein | Undisclosed |
Undisclosed |
Completed | Undisclosed |
| RK020 | Protein | Undisclosed |
Undisclosed |
Completed | Undisclosed |
Supporting protein engineering in the pharmaceutical,
chemical, environmental,
and food industries with cutting-edge AI technology
- High-accuracy learning from even limited experimental data
- Applicable to proteins without established databases
- Project-specific models with no cross-client reuse
